Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, develo...
Piramal Pharma reported revenue of 90.61 billion INR for fiscal year 2025, up 11.8% from fiscal year 2024, and net income of 911.30 million INR. In Q1 2026 (the quarter ended June 30, 2025) revenue was 19.34 billion INR, down 0.9% from a year before. outside India was its largest region in fiscal year 2025, with 82% of revenue. Its market capitalization was 260.58 billion INR as of October 12, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 12, 2026.
No profile data available.